Login to My NLA Account

Lipid Insights

 

Tune in quarterly and hear from expert speakers to gain insights on some of the leading topics in the field of lipidology. Listen below or download the podcast to listen later.

 

Hosted by:

Alan S. Brown, MD, FNLA
Clinical Associate Professor of Medicine and Cardiology at Loyola Stritch School of Medicine
Director, Division of Cardiology at the Advocate Heart Insiute at Advocate Lutheran General Hospital in Park Ridge, IL
Co-Director of the Cardiology Service Line for Advocate Medical Group/Advocate Health Care
Park Ridge, IL

 

S4E2: Nutrition Interventions for Adults with Dyslipidemia

Guest Speakers:
Zareen Farukhi, MD, MPH Carol F. Kirkpatrick, PhD, MPH, RDN, CLS, FNLA
Clinical Scientist
MB Clinical Research & Consulting, LLC
Addison, IL

 

Rachel Bond, MD, FACCKevin C. Maki, PhD, CLS, FNLA, FTOS, FACN
President and Chief Scientist
Midwest Biomedical 
Addison, IL and Bonita Springs, FL
Adjunct Professor, Dean's Eminent Scholar, Indiana University School of Public Heath Bloomington, IN                                                           

Alan Brown, MD, FNLA talks with Carol F. Kirkpatrick, PhD, MPH, RDN, CLS, FNLA and Kevin C. Maki, PhD, CLS, FNLA, FTOS, FACN to discuss nutrition interventions for adults with Dyslipidemia.

S4E1: The Importance of Low-Density Lipoprotein Cholesterol Measurement and Control as Performance Measures

Guest Speaker:

Christie M. Ballantyne, MD, FNLA Christie M. Ballantyne, MD, FNLA
Chief, Sections of Cardiology and Cardiovascular Research
Professor of Medicine, Molecular & Human Genetics, and Molecular Physiology & Biophysics
J.S. Abercrombie Chair, Atherosclerosis & Lipoprotein Research
Director, Center for Cardiometabolic Disease Prevention
Baylor College of Medicine
Houston, TX

Alan Brown talks with Christie M. Ballantyne, MD, FNLA about the importance of low-density lipoprotein cholesterol measurement and control as performance measures.

S3E2: Statin Underuse Persistence

Guest Speaker:

Kim Birtcher, MD Mary Katherine Cheeley, PharmD, FNLA
Executive Director and Clinical Pharmacist
Lipid Clinic
Grady Health System
Atlanta. GA

Alan Brown talks with Mary Katherine Cheeley, PharmD, FNLA about the persistent under-utilization of statins.

S3E1: Tables Turned

Guest Interviewer:

Kim Birtcher, MD Daniel E. Soffer, MD, FNLA
University of Pennsylvania Health System
Internal Medicine/Clinical Lipidology
Perelman Center for Advanced Medicine
Philadelphia, PA

This episode turns the tables as NLA's own Dan Soffer pitches the questions to Lipid Insights regular host Alan Brown.

S2E6: Women's Cardiovascular Health

Guest Speakers:

Zareen Farukhi, MD, MPH Zareen Farukhi, MD, MPH
Associate Physician
Brigham and Women's Hospital
Instructor in Medicine
Harvard University
Boston, MA

 

Rachel Bond, MD, FACC Rachel Bond, MD, FACC
System Director for Women's Health
Dignity Health
Assistant Professor of Medicine
Creighton University Chandler, AZ

Additional Materials:

There are no associated additional materials for this episode.

S2E5: Practical Approaches to Cardiovascular Risk Reduction in the Era of PCSK9 Inhibitors

Guest Speaker:

Kim Birtcher, MD Kim K. Birtcher, PharmD, FNLA
Clinical Professor at the University of Houston College of Pharmacy
Houston, TX

Additional Materials:

Improving Access to PCSK9-modulating Therapy (PDF Slides)

AJHP 2021 Pharmacist-administered long-acting injectable PCSK9 service-a solution to improve patient access and adherence (Journal Article)

S2E4: Genetic Variations in Patients with Very High LDL Cholesterol Including Familial Hypercholesterolemia

Guest Speaker:

Mark Trinder, MsC Mark Trinder, MsC
MD/PhD Candidate
2020 Donald Hunninghake, MD, Familial Hypercholesterolemia (FH) Abstract Award Winner
University of British Columbia
Vancouver, BC

Additional Materials:

There are no associated additional materials for this episode.

S2E3: Evinacumab: A New Therapuetic Option for Treating Dyslipidemia

Guest Speaker:

Robert Rosenson, MD, FNLA Robert Rosenson, MD, FNLA
Director of Cardiometabolic Disorders
Professor of Medicine
Mt. Sinai Ichan School of Medicine
New York, New York

Additional Materials:

There are no associated additional materials for this episode.

S2E2: CAC Scoring: A Discussion on the Recent NLA Scientific Statement

Guest Speakers:

Carl Orringer, MD, FNLA Carl Orringer, MD, FNLA
Associate Professor of Clinical Medicine
Director of Preventive Cardiovascular Medicine
University of Miami Miller School of Medicine
Miami, FL

 

Michael Blaha, MD Michael Blaha, MD
Director of Clinical Research
Johns Hopkins Ciccarone Center for the Prevention of Heart Disease
Baltimore, MD

Additional Materials:

Coronary Artery Calcium Scoring to Guide Prevention of ASCVD: A Scientific Statement from the NLA

S2E1: Omega 3 Outcome Trials in Perspective Part 1 and 2

Guest Speakers:

Christie M. Ballantyne, MD, FNLA Christie M. Ballantyne, MD, FNLA
Chief, Sections of Cardiology and Cardiovascular Research
Professor of Medicine, Molecular & Human Genetics, and Molecular Physiology & Biophysics
J.S. Abercrombie Chair, Atherosclerosis & Lipoprotein Research
Director, Center for Cardiometabolic Disease Prevention
Baylor College of Medicine
Houston, TX

 

Deepak Bhatt, MD, MPH Deepak Bhatt, MD, MPH
Executive Director of Interventional Cardiovascular Programs
Professor, Harvard Medical School
Brigham and Women's Hospital
Boston, MA

Additional Materials:

There are no associated additional materials for these episode.

S1E4: Special Edition: New Lipid Therapies

>Guest Speakers:

Christie M. Ballantyne, MD, FNLA Christie M. Ballantyne, MD, FNLA
Chief, Sections of Cardiology and Cardiovascular Research
Professor of Medicine, Molecular & Human Genetics, and Molecular Physiology & Biophysics
J.S. Abercrombie Chair, Atherosclerosis & Lipoprotein Research
Director, Center for Cardiometabolic Disease Prevention
Baylor College of Medicine
Houston, TX

 

R. Scott Wright, MD R. Scott Wright, MD
Professor of Medicine
Consultant, Division of Cardiovascular Disease
Mayo Clinic
Rochester, MN

Additional Materials:

There are no associated additional materials for this episode.

S1E3: Genetic Testing in Dyslipidemia

Guest Speaker:

Rob Hegele, MD Rob Hegele, MD
Director of the Blackburn Cardiovascular Genetics Laboratory
Robarts Research Insitute
London, Ontario

Additional Materials:

Genetic Testing in Dyslipidemia: A Scientific Statement from the National Lipid Association

S1E2: General Gaps in FH Care

Guest Speaker:

David Davidson, MD, FNLA David Davidson, MD, FNLA
Cardiologist at NorthShore Medical Group
Chicago, IL

Additional Materials:

How Well do Cardiologists and Primary Care Physicians Recognize and Treat Heterozygous Familial Hypercholesterolemia: A Survey from the National Lipid Association

Serving the Underserved: Are We Overlooking HoFH Patients?

S1E1: Clinical Pearls on Provider Methods for Obtaining Prior Authorizations for PCSK9i

Guest Speaker:

Kim K. Birtcher, PharmD, FNLA Kim K. Birtcher, PharmD, FNLA
Clinical Professor at the University of Houston College of Pharmacy
Houston, TX

Additional Materials:

Checklist for Seeking Approval for a PCSK9 Inhibitor

Overcoming the Challenges of Prior Authorization

 

Publish Date: 
Friday, March 27, 2020 - 11:45

This page was last updated: Jul 31, 2023